Rani Therapeutics Holdings (RANI) Shares Issued (2021 - 2026)
Rani Therapeutics Holdings (RANI) posted quarterly Shares Issued of $12.7 million for Q1 2026, up 11.85% year-over-year from $11.4 million in Q1 2025, and down 1.06% quarter-over-quarter from $12.9 million in Q4 2025.
Rani Therapeutics Holdings (RANI) Shares Issued (2021 - 2026) Analysis & Trends
Rani Therapeutics Holdings' Shares Issued history runs 6 years deep, the most recent figure standing at $12.7 million for Q1 2026.
- In Q1 2026, Shares Issued rose 11.85% year-over-year to $12.7 million; the TTM figure through Mar 2026 stood at $12.7 million (up 11.85% YoY), while the FY2025 annual figure was $12.9 million, up 25.84% from the prior year.
- Shares Issued for Q1 2026 stood at $12.7 million, down from $12.9 million in the prior quarter.
- The five-year high for Shares Issued was $12.9 million in Q4 2025, with the low at $851908.0 in Q3 2022.
- The 5-year median for Shares Issued is $6.4 million (2025), against an average of $6.9 million.
- The sharpest annual moves came in 2022 and 2023: Shares Issued sank 99.84% in 2022, then surged 75.26% in 2023.
- Rani Therapeutics Holdings' Shares Issued stood at $3.8 million in 2022, then surged by 75.26% to $6.6 million in 2023, then surged by 54.0% to $10.2 million in 2024, then climbed by 25.84% to $12.9 million in 2025, then slipped by 1.06% to $12.7 million in 2026.
- Business Quant data shows RANI's Shares Issued at $12.7 million in Q1 2026, $12.9 million in Q4 2025, and $6.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | - |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | Rani Therapeutics Holdings | 160.33 Mn | 160.33 Mn | - | 20.99 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 20.99 Bn |
| Jun 30, 2026 | 20.99 Bn |
| Mar 31, 2026 | 12.73 Mn |
| Mar 31, 2026 | 12.73 Mn |
| Dec 31, 2025 | 12.87 Mn |
| Dec 31, 2025 | 12.87 Mn |
| Sep 30, 2025 | 6.40 Mn |
| Sep 30, 2025 | 6.40 Mn |
| Jun 30, 2025 | 6.46 Mn |
| Jun 30, 2025 | 6.46 Mn |
| Mar 31, 2025 | 11.38 Mn |
| Mar 31, 2025 | 11.38 Mn |
| Dec 31, 2024 | 10.23 Mn |
| Dec 31, 2024 | 10.23 Mn |
| Sep 30, 2024 | 4.71 Mn |
| Sep 30, 2024 | 4.71 Mn |
| Dec 31, 2023 | 6.64 Mn |
| Dec 31, 2023 | 6.64 Mn |
| Dec 31, 2022 | 3.79 Mn |
| Dec 31, 2022 | 3.79 Mn |